ClinicalTrials.Veeva

Menu
N

North Bay Eye Associates | Petaluma, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Latanoprost
Netarsudil
Timolol Maleate
Bimatoprost
DE-117
KPI-121
Azithromycin
RVL-1201
DE-126
AGN-195263

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 51 total trials

A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Pseudophakic Eyes (EVOLVE)

A Randomized Clinical Trial of Ab Interno Canaloplasty and Trabeculotomy with the OMNI® Surgical System Compared to Standard Medical Treatment in Pse...

Enrolling
Primary Open Angle Glaucoma
Drug: Latanoprost plus adjunctive glaucoma medication
Device: OMNI Surgical System

This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonst...

Enrolling
Ocular Hypertension
Glaucoma, Open-Angle
Drug: Test - Bimatoprost 0.01% Ophthalmic Solution
Drug: Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)

The main purpose is to compare the ocular hypotensive efficacy and safety of two concentrations of T4090 (Kinezodianone R HCl 0.2% and 0.3%) ophthalm...

Active, not recruiting
Glaucoma
Ocular Hypertension
Drug: Rhopressa®
Drug: T4090 0.3%

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hyper...

Invitation-only
Open-Angle Glaucoma
Ocular Hypertension
Drug: Bimatoprost SR
Other: Standard of Care

The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects...

Enrolling
Open Angle Glaucoma
Ocular Hypertension
Drug: AR-17043 Ophthalmic Solution
Drug: Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic Solution

This study evaluates the reliability, validity and safety of a self administered, subjective refraction test via a mobile medical app (GoEyes) as com...

Enrolling
Refractive Errors
Diagnostic Test: Mobile medical application to self administer a subjective refraction test
Diagnostic Test: Standard of care refraction test

Trial sponsors

Allergan logo
Aerie Pharmaceuticals logo
S
AbbVie logo
Glaukos logo
K
Merck Sharp & Dohme (MSD) logo
R
S
Shire logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems